BetaEntity Annotation Prototype

Entity family

Browse treatments

Clinical therapies and care approaches used to manage a condition. Examples include immunotherapy, radiotherapy, rehabilitation.

7,227articles mentioning treatments
16,644treatment mentions
4,719distinct treatments extracted
0%of mentions human-reviewed

All extracted treatments

Showing 2,341–2,400 of 4,719, ordered by supporting articles. Choose a treatment to see its evidence.

Interferential therapy (IFT)1Intestinal transplant1Intestinal ultrasound1Intra-articular corticosteroid (IACS) injection1Intra-articular corticosteroid injections1Intracerebral dopamine cell transplants1Intralesional corticosteroid therapy1Intrapleural fibrinolytic treatment1Intrasaccular flow disruption1Intrathecal drug delivery1Intratympanic steroid therapy1Intravenous (IV) fluid therapy1Intravenous medicine administration1Intravenous potassium supplementation1Intravesical BCG instillations1Intravitreal antivascular endothelial growth factor (anti-VEGF) therapy1Intravitreal therapies1Irreversible electroporation (IRE)1JAK inhibitors1Joint replacement1Jugular vein stenting1K-wire fixation1Ketamine-assisted psychotherapy1LAMS1LD-XRT1LDKTrelativeyearsgained1LDKTsurvival1LN induction treatment1LPA-targeted therapies1LRT1LTNIV1LV lead placement1LVAD implantation1LVR1Labor analgesia1Labour epidural analgesia1Laparoscopic surgery1Laparoscopy1Lateral femoral cutaneous nerve block1Left atrial ablation1Left ventricular assist devices1Level 1 disability management1Lipid Lowering TherapyPrescribed1Lipid-lowering therapies1Lokomat rehabilitation1Long term dopamine agonist therapy1Long-acting antiretroviral therapy1Long-acting injectable antiretroviral therapy1Low-dose ketamine infusion1Lumbar spine surgeries1Lymphatic Microsurgical Preventive Healing Approach1Lymphaticovenous anastomosis (LVA)1MATRix protocol1MB-TRAIL M28z CAR-T cell therapy1MBC regimen1MBE1MCMV peptide-epitope therapy1MDMA-assisted psychotherapy1MDT1MDT therapy programmes1

Articles mentioning treatments

7,227 articles · page 390 of 603
Chimeric Antigen Receptor T-cell (CAR-T) therapyaxicabtagene ciloleuceltisagenlecleucelciltacabtagene autoleucelmultiple myelomaDLBCLanakinraacute lymphoblastic leukaemiadiffuse large B-cell lymphomaICANS+1 more

…Background and Importance Chimeric Antigen Receptor T-cell (CAR-T) therapy has improved outcomes in relapsed or refractory haematological …

DAPTaspiriniP2Y12chronic kidney diseaseacute myocardial infarctionatrial fibrillationdiabetes mellitustertiary hospitalNon-ST-segment Elevation Myocardial InfarctionST-segment elevation myocardial infarction+5 more

…in discharge treatment between men and women were observed (eg, DAPT and anticoagulation), these were not statistically significant.…

CAR T-cell therapyECOG Performance StatusTisagenlecleucelKymriahhematologic malignanciesTecartusbrexucabtagén autoleucelYescartaAxicabtagén ciloleucelmantle cell lymphoma+5 more

…pitalisation was 23.5 days (IQR 17-28).Conclusion and Relevance CAR T-cell therapy in real-world-practice achieves high early response rates, alth…

corticosteroid therapyipilimumablevofloxacinnivolumabprednisoneipilimumab/nivolumabamoxicillin–clavulanatelevetiracetamadvanced clear-cell renal carcinoma

…diated origin of hepatic and neurological alterations optimised corticosteroid therapy and improved patient safety.Material and Methods Ipilimumab/niv…